On Friday, Eli Lilly unveiled designs on a new, $3.5 billion manufacturing facility in Pennsylvania’s Lehigh Valley, rounding ...

Eli Lilly plans to invest more than $3.5 billion in a new injectable medicine and device manufacturing facility in Pennsylvania. The Lehigh Valley site will manufacture next-generation weight-loss ...

Drugmaker Eli Lilly and Co. says it'll build a $3.5 billion manufacturing facility in Pennsylvania, as the company expands ...

Eli Lilly and Company recently announced plans to invest more than US$3.50 billion in a new Lehigh Valley, Pennsylvania ...

Eli Lilly announced Friday that it will invest over $3.5 billion in a new injectable medicine and device manufacturing ...

Drugmaker Eli Lilly and Co. says the $3.5 billion manufacturing facility in Fogelsville, just outside Allentown, will make injectable drugs and devices.

Historically a steel production hub, Lehigh Valley will now help manufacture Lilly’s weight loss drug hopeful retatrutide.

The new facility, part of a $27 billion reshoring investment, will produce the drugmaker's weight-loss therapies.

The pharmaceutical giant plans to build a 925K SF weight-loss-centric manufacturing plant in the Lehigh Valley's Upper ...

Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...

North Natomas just handed over one of its key industrial addresses to its longtime tenant, as Nivagen Pharmaceuticals has bought the building it already occupies at 3900 Duckhorn Drive in Sacramento.